Mark Frohlich

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

New England Journal of Medicine · 2010 · 4,436 citations

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

Cancer · 2009 · Last of 8 authors · 645 citations